InterMune Shares Rise On FDA Panel Recommendation

The recommendation caused a 64 percent jump in InterMune stock prices and fueled speculation that the Brisbane, Calif.-based company is ripe for acquisition.

Read more »

GlaxoSmithKline, Pfizer Team Up Against HIV

The collaboration of two pharmaceutical giants may mark the beginning of an industry shift. Pfizer and GlaxoSmithKline are combining their HIV drug businesses into a single, jointly owned company that will account for almost 20 percent of the market.

Read more »